For Investors

Press Releases

ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares and Warrants

10/26/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Oct. 26, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ ReWalk ” or the “ Company ”) today announced that it intends to commence an underwritten public offering of units, which consist of ordinary shares of the Company and warrants to

Read More
Read More

ReWalk Robotics to Discuss 2016 Third Quarter Financial Results on November 3, 2016 Conference Call

10/25/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Oct. 25, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK), the leading global exoskeleton developer and manufacturer, will release its 2016 third quarter financial results on Thursday, November 3, 2016 , before the U.S.

Read More
Read More

ReWalk Robotics Achieves Milestone of 100 Personal Systems Sold

09/07/16

Leading Exoskeleton Manufacturer Establishes Global Footprint Across North America, EU, Asia & Pacific YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Sept. 7, 2016 /PRNewswire/ -- ReWalk Robotics Ltd.  (Nasdaq: RWLK) ("ReWalk" or the "Company"), the leading global exoskeleton developer and

Read More
Read More

ReWalk Robotics to Present at Canaccord Genuity Growth Conference 2016

08/05/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Aug. 05, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or “the Company”) (Nasdaq:RWLK) today announced that Kevin Hershberger , Chief Financial Officer, will present at the Canaccord Genuity Growth Conference 2016 in Boston as follows: Date:  

Read More
Read More

ReWalk Robotics Reports Second Quarter 2016 Financial Results

08/04/16

Placed 24 Personal Units, 18 of which were covered by insurance YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Aug. 04, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced its financial results for the three- and six-month periods ended June 30,

Read More
Read More

German Social Court Ruling Deems ReWalk Exoskeleton Medically Necessary as Medical Aid for Recipient with Spinal Cord Injury

08/04/16

Social Welfare Court Decision in Germany: Reimbursement Approved on Appeal YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Aug. 4, 2016 /PRNewswire/ --  ReWalk Robotics (NASDAQ: RWLK), the leading developer and manufacturer of exoskeletons, announced the first ruling by the Social Welfare Court of

Read More
Read More

ReWalk Announces Launch of 522 Post-Market Study with Stanford University School of Medicine as Lead Investigator Site

08/02/16

Oracle Contracted for Electronic Data Capture System to Manage Study Data YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Aug. 2, 2016 /PRNewswire/ -- Leading exoskeleton manufacturer and developer ReWalk Robotics (NASDAQ: RWLK) announced the initiation of its U.S.

Read More
Read More

ReWalk Robotics to Discuss 2016 Second Quarter Financial Results on August 4, 2016 Conference Call

07/25/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , July 25, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK), the leading global exoskeleton developer and manufacturer, will release its 2016 second quarter financial results on Thursday, August 4, 2016 , before the U.S. financial markets open.

Read More
Read More

ReWalk Robotics to Present at Jefferies Healthcare Conference

05/31/16

YOKNEAM ILLIT, Israel and MARLBOROUGH, Mass. , May 31, 2016 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or “the Company”) (Nasdaq:RWLK) today announced that Larry Jasinski , Chief Executive Officer, and Kevin Hershberger , Chief Financial Officer, will present at the Jefferies 2016

Read More
Read More

ReWalk Robotics to Present at Oppenheimer 17th Annual Israeli Conference on May 22nd in Tel Aviv

05/17/16

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , May 17, 2016 (GLOBE NEWSWIRE) -- Kevin Hershberger , Chief Financial Officer of ReWalk Robotics Ltd. (Nasdaq:RWLK), will present at the Oppenheimer 17 th Annual Israeli Conference as follows:    Date:    Sunday, May 22, 2016 Time:    10:50 a.m.

Read More
Read More

ReWalk Announces Collaboration with Harvard University's Wyss Institute to Develop Lightweight and Soft Exoskeleton Systems for the Treatment of Stroke, Multiple Sclerosis and Limited Mobility Patients

05/17/16

Five-Year Agreement Establishes Unique Collaboration and Extensive IP Licensing for "Soft Suit" Exoskeleton Systems YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , May 17, 2016 /PRNewswire/ --  ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or "Company"), the leading global exoskeleton developer and

Read More
Read More

Commercial Health Insurance Company Becomes First to Implement Medical Policy Finding Powered Exoskeletons Medically Necessary

05/09/16

First Rewalk Device Reimbursed as Part of Comprehensive Policy Issued by Commercial Insurer YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , May 9, 2016 /PRNewswire-USNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk"), the leading global exoskeleton developer and manufacturer, announced today

Read More
Read More
Displaying 205 - 216 of 281